PubRank

P Birrer

Author PubWeight™ 23.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med 1992 2.57
2 Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992 2.33
3 Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 1993 2.07
4 Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet 1991 2.05
5 Comparison of midazolam and diazepam for conscious sedation in the emergency department. Ann Emerg Med 1993 1.48
6 Pulmonary surfactant in cystic fibrosis. Eur Respir J 1997 1.22
7 Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol (1985) 1993 1.02
8 Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 2001 0.99
9 A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease. Eur J Pediatr 1992 0.87
10 Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis. Electrophoresis 2001 0.86
11 Dose-response relationships and time course of the response to systemic beta adrenoreceptor agonists in infants with bronchopulmonary disease. Thorax 1988 0.82
12 Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration 1997 0.82
13 Genotype-phenotype association in infants with cystic fibrosis at the time of diagnosis. Pediatr Res 1998 0.81
14 Short-time response characteristics of salbutamol in infants with broncho-pulmonary diseases. Eur J Clin Pharmacol 1988 0.80
15 Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis. Arch Dis Child 2003 0.79
16 Mycobacterium genavense invasive infection in two children with AIDS: long-term followup. Eur J Pediatr 1995 0.77
17 Inhalation of alpha(1)-protease inhibitor in cystic fibrosis does not affect surfactant convertase and surface activity. Pulm Pharmacol Ther 2001 0.77
18 [PFAPA syndrome: periodic fever, adenitis, pharyngitis and aphthous stomatitis]. Schweiz Med Wochenschr 1997 0.76
19 Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis. Am J Nephrol 1995 0.76
20 Antipyretic effect of parenteral paracetamol (propacetamol) in pediatric oncologic patients: a randomized trial. Pediatr Hematol Oncol 1997 0.75
21 Bronchodilator responsiveness in a ventilator-dependent infant with severe tracheobronchomalacia. Intensive Care Med 1999 0.75
22 [Invasive Pseudomonas aeruginosa and Ecthyma gangrenosum infection in a child without risk factors]. Arch Pediatr 1996 0.75